| AQS Stock | | | CAD 0.01 0.01 100.00% |
Aequus Pharmaceuticals financial indicator trend analysis is way more than just evaluating Aequus Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aequus Pharmaceuticals is a good investment. Please check the relationship between Aequus Pharmaceuticals Property Plant And Equipment Net and its Accounts Payable accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Aequus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Property Plant And Equipment Net vs Accounts Payable
Property Plant And Equipment Net vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Aequus Pharmaceuticals Property Plant And Equipment Net account and
Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Aequus Pharmaceuticals' Property Plant And Equipment Net and Accounts Payable is -0.23. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Aequus Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Aequus Pharmaceuticals' Property Plant And Equipment Net and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Aequus Pharmaceuticals are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Property Plant And Equipment Net i.e., Aequus Pharmaceuticals' Property Plant And Equipment Net and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.23 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Accounts Payable
An accounting item on the balance sheet that represents Aequus Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Aequus Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Aequus Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aequus Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Aequus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
At this time, Aequus Pharmaceuticals'
Selling General Administrative is fairly stable compared to the past year.
Sales General And Administrative To Revenue is likely to climb to 8.81 in 2024, whereas
Enterprise Value Over EBITDA is likely to drop
(3.21) in 2024.
Aequus Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Aequus Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aequus Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to
measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.